论文部分内容阅读
鳞状上皮细胞癌抗原(squamous cell carcinoma antigen,SCCAg)是近年来发现的一种特异性高的肿瘤标志物,检测血清中SCCAg的水平常被应用于多种器官鳞状细胞癌的临床诊断、预后评估、病情监测和疗效评价等。SCCAg与其他肿瘤标志物的联合检测,可有效提高肿瘤临床诊断的灵敏度,对肿瘤的早期诊断、疗效评价、预后监测等有重要的临床意义。
Squamous cell carcinoma antigen (SCCAg) is a highly specific tumor marker found in recent years. The detection of serum SCCAg level is often used in the clinical diagnosis of multiple organ squamous cell carcinomas, Prognosis assessment, disease monitoring and evaluation of efficacy. The joint detection of SCCAg and other tumor markers can effectively improve the sensitivity of clinical diagnosis of tumors and has important clinical significance for the early diagnosis of tumor, evaluation of curative effect and prognosis monitoring.